Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Study Reveals Resistance to Change in Cervical Cancer Screenings
From - Diagnostic Testing & Emerging Technologies
The majority of women are willing to undergo less frequent cervical cancer screening, consistent with screening guidelines, if it was…
Large-Scale Sequencing Initiatives Further Precision Medicine
From - Diagnostic Testing & Emerging Technologies
Large-scale sequencing initiatives performed in integrated health care systems, such as the DiscovEHR collaboration, can advance genetic discovery and serve as a…
4Q Earnings Show Mostly Gains for Diagnostics
...
Already a member? Log in here
Initiatives Seek to Demonstrate Clinical Utility of Premptive PGx Testing
...
Already a member? Log in here
FDA and Health Orgs Renew Focus on LDT Oversight
...
Already a member? Log in here
Increased Genetic Counseling Needed for Breast Cancer Patients
From - Diagnostic Testing & Emerging Technologies
Physicians often fail to recommend genetic testing for breast cancer patients at high risk for mutations, according to a research letter published Feb…
iSpecimen Creates Marketplace for Clinical Discards
...
Already a member? Log in here
Updated Guidelines Emphasize Newer Tests for TB Diagnosis
...
Already a member? Log in here
2016 Investments Steady, Exits Decline
From - Diagnostic Testing & Emerging Technologies
Investments in the diagnostics and tools (Dx/Tools) sector remained steady in 2016, according to Silicon Valley Bank's annual report…